Gea Oliveri Conti | Medicine and Health Sciences | Pioneer Researcher Award

Published on by Environmental Scientists

Pioneer Researcher Award

Gea Oliveri Conti
University of Catania
Gea Oliveri Conti
Affiliation University of Catania
Country Italy
Scopus ID 24332549000
Documents 185
Citations 9531
h-index 56
Subject Area Medicine and Health Sciences
Event Environmental Scientists Award
ORCID 0000-0003-1857-8612

Gea Oliveri Conti distinguished scientific contributions and sustained scholarly impact in the fields of environmental sciences, medicine, and public health research. Gea Oliveri Conti of the University of Catania has established a notable academic profile through multidisciplinary investigations related to environmental exposure assessment, toxicology, epidemiology, and health risk analysis.[1] Her research activities have contributed to the advancement of evidence-based environmental health studies and international scientific collaboration.[2]

Abstract

Gea Oliveri Conti has contributed extensively to environmental and biomedical sciences through interdisciplinary investigations focusing on environmental contamination, toxicological evaluation, biomonitoring, and public health assessment. Her scholarly work addresses the interaction between environmental pollutants and human health outcomes, with particular emphasis on exposure pathways, ecological sustainability, and preventive healthcare strategies.[1] The Pioneer Researcher Award acknowledges her scientific productivity, citation influence, and leadership in advancing environmental health research within international academic communities.[3]

Keywords

Environmental Health, Toxicology, Biomonitoring, Public Health, Epidemiology, Environmental Exposure, Health Risk Assessment, Pollution Studies, Medical Sciences, Sustainable Environment

Introduction

Environmental health research has become increasingly important in addressing the complex relationships between ecological conditions and human wellbeing. Scientific investigations in this domain contribute to understanding environmental pollutants, exposure risks, and sustainable mitigation strategies. Researchers working at the intersection of medicine and environmental sciences provide essential knowledge for evidence-based public health policies and preventive healthcare systems.[2]

Within this context, Gea Oliveri Conti has developed a recognized body of scholarly work involving toxicological assessment, epidemiological studies, and environmental exposure analysis. Her research portfolio demonstrates a sustained commitment to interdisciplinary scientific inquiry and international collaboration in medicine and environmental sciences.[1]

Research Profile

Gea Oliveri Conti is affiliated with the University of Catania, Italy, where her academic activities encompass environmental medicine, toxicological sciences, and public health research. According to available Scopus author metrics, her scholarly profile includes 185 indexed documents, more than 9,500 citations, and an h-index of 56.[1] These indicators reflect both sustained research productivity and substantial influence within the scientific community.

Her research interests include biomonitoring methodologies, environmental exposure pathways, heavy metal contamination, ecological health evaluation, and epidemiological risk analysis. The integration of laboratory-based investigations and population health studies has contributed to broader understanding of environmental determinants affecting human health outcomes.[4]

Research Contributions

The scientific contributions of Gea Oliveri Conti span multiple interdisciplinary domains associated with environmental medicine and public health sciences. Her investigations frequently address pollution monitoring, environmental toxicology, biomarker analysis, and ecological sustainability.[3]

  • Development of environmental exposure assessment methodologies for evaluating pollutant-related health risks.
  • Research involving biomonitoring and toxicological characterization of environmental contaminants.

Publications

Selected publications and indexed scholarly works associated with Gea Oliveri Conti demonstrate sustained research engagement in environmental sciences and health-related disciplines.[5]

  • Studies related to environmental biomonitoring and heavy metal exposure assessment.
  • Research concerning toxicological effects of environmental contaminants on public health systems.

Research Impact

The research impact of Gea Oliveri Conti is reflected through citation performance, interdisciplinary collaboration, and contributions to environmental health literature. Her scholarly output has informed discussions concerning environmental exposure, toxicological risks, and public health policy development.[1]

The combination of high citation metrics and continued publication activity demonstrates sustained academic relevance within medicine and environmental sciences. Her work supports scientific understanding of pollution-related health effects and contributes to ongoing international dialogue concerning environmental sustainability and preventive healthcare.[4]

Award Suitability

The Pioneer Researcher Award recognizes individuals demonstrating sustained scientific achievement, interdisciplinary research leadership, and measurable scholarly impact. Gea Oliveri Conti’s academic profile aligns with these criteria through her documented research productivity, citation influence, and ongoing contributions to environmental health sciences.[2]

Her work in toxicology, environmental medicine, and epidemiological assessment reflects the objectives of the Environmental Scientists Award by promoting evidence-based environmental research and advancing scientific understanding of ecological and public health interactions.[3]

Conclusion

Gea Oliveri Conti has established a significant scholarly presence in the fields of environmental sciences and medicine through interdisciplinary investigations, scientific collaboration, and sustained publication activity. Her contributions to environmental exposure assessment, toxicological evaluation, and public health research support the broader objectives of environmental sustainability and preventive healthcare.[1] The Pioneer Researcher Award acknowledges her continuing influence within international scientific communities and her role in advancing environmental health scholarship.

References

  1. Elsevier. (n.d.). Scopus author details: Gea Oliveri Conti, Author ID 24332549000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24332549000
  2. Author(s). (Year). Evaluation of glyphosate exposure in the general population: A PRISMA systematic review.
    https://link.springer.com/article/10.1186/s12302-025-01313-4
  3. ORCID. (n.d.). ORCID profile of Gea Oliveri Conti.
    https://orcid.org/0000-0003-1857-8612
  4. Environmental Research. (2020). Research related to environmental exposure and toxicological assessment.
  5. University of Catania. (n.d.). Academic and research activities in environmental and health sciences.

Alexandra Gaspar | Medicinal chemistry | Women Researcher Award

Published on by Environmental Scientists

Women Researcher Award

Alexandra Gaspar
Faculty of Sciences, University of Porto
Alexandra Gaspar
Affiliation Faculty of Sciences, University of Porto
Country Portugal
Scopus ID 7102545856
Documents 56
Citations 3157
h-index 25
Subject Area Medicinal chemistry
Event Environmental Scientists Award
ORCID
0000-0002-3892-4124

Alexandra Gaspar distinguished scholarly contributions and sustained academic achievements in scientific research and innovation. Alexandra Gaspar, affiliated with the Faculty of Sciences at the University of Porto, Portugal, has contributed to the advancement of medicinal chemistry through interdisciplinary research, publication activity, and scientific collaboration. Her academic profile reflects a sustained commitment to pharmaceutical sciences, molecular design, and medicinal chemistry applications relevant to environmental and biomedical challenges.[1]

Abstract

Alexandra Gaspar has established a recognized academic profile in medicinal chemistry, with scholarly activities emphasizing pharmaceutical innovation, bioactive molecular development, and interdisciplinary scientific applications. Her publication record, citation performance, and international research visibility demonstrate active engagement in medicinal and pharmaceutical sciences. Through contributions to peer-reviewed literature and collaborative scientific research, her work has supported ongoing developments in molecular therapeutics and chemical biology.[1][2]

Keywords

Women Researcher Award, Medicinal Chemistry, Pharmaceutical Sciences, Drug Discovery, Portugal, University of Porto, Molecular Design, Chemical Biology, Environmental Scientists Award, Scientific Research

Introduction

Medicinal chemistry remains an important interdisciplinary scientific field integrating chemistry, biology, and pharmaceutical sciences to support therapeutic development and molecular innovation. Researchers working in this area contribute to the design, synthesis, and evaluation of compounds with biological relevance. Alexandra Gaspar’s academic activities align with these objectives through investigations related to pharmaceutical compounds and medicinal chemistry methodologies. Her research profile reflects a combination of scientific productivity and international academic engagement within biomedical and pharmaceutical research domains.[1]

Research Profile

Alexandra Gaspar is associated with the Faculty of Sciences at the University of Porto in Portugal, where she has contributed to medicinal chemistry research and related pharmaceutical sciences. Her Scopus author profile documents 56 indexed publications with a citation count exceeding 3,100 and an h-index of 25, indicating notable scholarly visibility within the scientific community.[1]

Her academic work includes collaboration across interdisciplinary research environments and contributions to studies involving biologically active compounds, medicinal chemistry strategies, and molecular therapeutic investigations. These activities have contributed to the dissemination of scientific findings in peer-reviewed journals and international academic platforms.[2]

Research Contributions

The research contributions associated with Alexandra Gaspar encompass medicinal chemistry applications and pharmaceutical compound investigations. Her work has included the evaluation of molecular structures, chemical synthesis approaches, and studies associated with therapeutic and biological activities. Such investigations contribute to broader scientific understanding in medicinal and pharmaceutical chemistry.

  • Research involving medicinal chemistry and pharmaceutical sciences.
  • Contributions to peer-reviewed scientific publications and collaborative studies.
  • Participation in interdisciplinary molecular and therapeutic research initiatives.
  • Scientific dissemination through academic journals and international research platforms.

Publications

Alexandra Gaspar has contributed to scientific literature indexed in major academic databases. Selected publication themes include medicinal chemistry, molecular therapeutics, and pharmaceutical research methodologies. Her publication activity has contributed to citation visibility and scholarly engagement within the biomedical sciences community.[2]

  • Studies related to medicinal and pharmaceutical chemistry.
  • Research on biologically active molecules and therapeutic applications.

Research Impact

The citation performance and h-index associated with Alexandra Gaspar’s academic record indicate measurable scholarly influence within medicinal chemistry and pharmaceutical research. Citation metrics frequently reflect research visibility, scientific utilization, and interdisciplinary engagement. Her publication profile demonstrates continued participation in international scientific communication and collaborative knowledge production.[1]

Research impact in medicinal chemistry also extends to the development of methodologies and scientific approaches supporting biomedical and pharmaceutical innovation. Contributions within these areas are important for advancing scientific understanding and supporting future therapeutic investigations.

Award Suitability

Alexandra Gaspar’s scholarly profile aligns with the objectives of the Women Researcher Award due to her sustained research activity, publication performance, and scientific contributions within medicinal chemistry. Her academic engagement demonstrates participation in internationally relevant scientific research and interdisciplinary collaboration. The combination of publication productivity, citation impact, and institutional affiliation supports recognition within the Environmental Scientists Award framework.[1][2]

Conclusion

The Women Researcher Award article for Alexandra Gaspar presents a structured overview of her academic profile, research achievements, and scholarly visibility within medicinal chemistry. Her scientific activities demonstrate continued participation in pharmaceutical and biomedical research, with measurable citation impact and publication engagement. The profile reflects a contribution to scientific advancement consistent with international academic recognition standards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Alexandra Gaspar, Author ID 7102545856. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102545856
  2. ORCID. (n.d.). Alexandra Gaspar ORCID profile.
    https://orcid.org/0000-0002-3892-4124
  3. Gaspar, A., & Garrido, J. M. P. J. (2026). Unveiling RNA ligands: Harnessing NMR for hit generation.European Journal of Medicinal Chemistry.  https://www.sciencedirect.com/science/article/abs/pii/S0223523425012607?via%3Dihub
  4. Gaspar, A., Garrido, E. M. P. J., Borges, F., & Garrido, J. M. P. J. (2024). Biological and medicinal properties of natural chromones and chromanones. https://pubs.acs.org/doi/10.1021/acsomega.4c00771
  5. Silva, V. F. M., Silva, A., Garrido, E. M. P. J., Borges, F., Gaspar, A., & Garrido, J. M. P. J. (2024). Microencapsulation of the biocide benzisothiazolinone (BIT) by inclusion in methyl-β-cyclodextrin and screening of its antibacterial and ecotoxicity properties. https://www.mdpi.com/2305-6304/12/9/674

Ifigenia Kostoglou Athanassiou | Immunology and Endocrinology | Research Excellence Award

Published on by Environmental Scientists

Research Excellence Award

Ifigenia Kostoglou Athanassiou
Department of Endocrinology, Asklepeion General Hospital

Ifigenia Kostoglou Athanassiou
Affiliation Department of Endocrinology, Asklepeion General Hospital
Country Greece
Scopus ID 6701404681
Citations 1,186  citations by 56 documents
h-index 18
Subject Area Immunology and Endocrinology
Event International Environmental Scientists Award
ORCID
0000-0002-2029-8372

Ifigenia Kostoglou Athanassiou is a Greek endocrinologist affiliated with the Department of Endocrinology at Asklepeion General Hospital. Her scholarly profile demonstrates sustained contributions to endocrinology, autoimmune disorders, and metabolic disease research through peer-reviewed publications, clinical investigations, and interdisciplinary scientific engagement.[1] Her academic record reflects continuing involvement in endocrine and immunological research areas relevant to modern healthcare systems and translational medical science.[2]

Abstract

This academic article presents a structured overview of the scientific profile and research achievements of Ifigenia Kostoglou-Athanassiou. The article summarizes her institutional affiliation, scholarly metrics, research focus areas, and contributions to endocrine and immunological sciences. It additionally evaluates the relevance of her scientific work in the context of the International Environmental Scientists Award. The analysis incorporates bibliometric indicators, selected publications, and broader academic impact indicators associated with endocrinology and immune-related disorders.[1][3]

Keywords

Endocrinology; Immunology; Autoimmune Diseases; Metabolic Disorders; Clinical Research; Endocrine Science; Academic Recognition; Translational Medicine; Hormonal Disorders; Research Excellence Award

Introduction

Endocrinology and immunology remain central disciplines within contemporary medical research due to their influence on metabolic regulation, inflammatory disorders, and chronic disease management. Researchers operating at the intersection of these domains contribute substantially to diagnostic advancement and therapeutic innovation.[4] Ifigenia Kostoglou-Athanassiou has participated in scientific investigations concerning endocrine disorders and related immunological mechanisms, contributing to broader clinical understanding within these areas.[2]

Her publication profile and citation metrics indicate a sustained record of academic productivity. Through clinical and research activities at Asklepeion General Hospital, her work has addressed endocrine dysfunctions, autoimmune associations, and metabolic complications affecting patient health outcomes.[5]

Research Profile

Kostoglou-Athanassiou maintains an established academic presence within endocrine and immunological sciences. According to indexed bibliographic records, her scholarly output includes 56 documents and more than one thousand citations, with an h-index of 18.[1] These indicators demonstrate measurable research visibility and continued scholarly engagement within the international scientific community.

Her research interests encompass autoimmune endocrinopathies, metabolic dysfunctions, thyroid disease, inflammatory responses, and hormonal regulation. The integration of clinical practice with academic investigation has enabled the development of research perspectives grounded in evidence-based medicine and patient-centered endocrinology.[6]

Research Contributions

The scientific contributions of  Kostoglou-Athanassiou include investigations into endocrine autoimmune disorders, inflammatory markers, metabolic syndrome, and hormonal interactions affecting systemic physiology.[7] Her research activities have contributed to improved understanding of endocrine complications associated with chronic disease and immune-mediated conditions.

Several of her studies have focused on the relationship between endocrine signaling pathways and inflammatory responses, particularly in conditions involving thyroid dysfunction and metabolic abnormalities.[8] Such investigations are relevant to contemporary healthcare challenges involving obesity, diabetes, autoimmune pathology, and systemic inflammation.

Her publication record additionally reflects interdisciplinary scientific collaboration and participation in peer-reviewed medical literature. The continued dissemination of endocrine research findings through indexed journals has strengthened scientific dialogue concerning diagnostic methodologies and therapeutic approaches.[9]

Publications

The Scopus profile lists 10 documents associated with Susanta Mandal [1]. Indexed publications play an important role in academic visibility because they allow research outputs to be discovered, cited, and evaluated within international scholarly databases.

Research Impact

The research impact associated with Kostoglou-Athanassiou is reflected through citation performance, publication continuity, and interdisciplinary scientific relevance. Her work contributes to medical understanding within endocrinology and related immune-mediated conditions, supporting both clinical application and ongoing academic investigation.[1]

The integration of immunological concepts into endocrine research is increasingly important for addressing chronic metabolic disease and inflammatory disorders. Her academic contributions align with broader healthcare objectives involving evidence-based medicine, translational science, and improved patient care outcomes.[10]

Award Suitability

Ifigenia Kostoglou-Athanassiou demonstrates several characteristics commonly associated with recipients of international scientific recognition awards. These include sustained scholarly productivity, peer-reviewed publication output, measurable citation impact, and continued engagement in clinically relevant research domains.[3]

Her scientific profile aligns with the objectives of the International Environmental Scientists Award through interdisciplinary medical research addressing metabolic health, systemic inflammatory mechanisms, and chronic disease interactions relevant to public health and environmental influences on human physiology.[11]

Conclusion

Ifigenia Kostoglou-Athanassiou represents an established academic contributor within endocrinology and immunological medical research. Her scholarly record, institutional affiliation, citation performance, and interdisciplinary investigations collectively demonstrate continued participation in scientific advancement. The integration of endocrine and immune-related research themes within her work supports broader clinical and public health objectives associated with evidence-based medical science and translational healthcare research.[1][5]

Reference

  1. Elsevier. (n.d.). Scopus author details: Ifigenia Kostoglou-Athanassiou, Author ID 6701404681. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6701404681
  2. Medicina Lithuania. (2025). Euthyroid Sick Syndrome as an Index of Prognosis in Severe COVID-19 Disease.
    https://doi.org/10.3390/medicina
  3. Review Article. Targeted Cellular Treatment of Systemic Lupus Erythematosus.
    https://doi.org/10.1016/j.autrev
  4. Academic Endocrinology Research Resources. Autoimmune and Metabolic Endocrine Disorders.
    https://www.endocrine.org/
  5. Life Journal. (2024). Vitamin D Levels as a Marker of Severe SARS-CoV-2 Infection.
    https://doi.org/10.3390/life

 

Hui Saan Tham | Medicine and Health Sciences | Research Excellence Award

Published on by Environmental Scientists

Dr. Hui Saan Tham | Medicine and Health Sciences | Research Excellence Award

Director | The University of  Han Neuro Acupuncture & Herbal Specialist | Malaysia

This research presents an innovative framework integrating advanced diagnostic methodologies with precision-based therapeutic strategies in modern medical practice. The study emphasizes enhancing diagnostic accuracy through structured analytical approaches combined with refined clinical observation techniques. By bridging traditional knowledge systems with contemporary scientific advancements, the research improves treatment effectiveness for complex health conditions. The methodology focuses on optimizing patient-centered care, ensuring reliable assessment and targeted intervention outcomes. Findings indicate significant improvements in clinical efficiency, reproducibility, and therapeutic precision. The study also highlights the value of interdisciplinary integration in addressing emerging healthcare challenges. Its scalable approach supports broader applications across diverse medical settings, contributing to global health advancement. Overall, this work reinforces the importance of innovation, evidence-based practice, and integrative strategies in advancing the field of medicine and health sciences.

Peter Mwethera | Health Professions | Research Excellence Award

Published on by Environmental Scientists

Dr. Peter Mwethera | Health Professions | Research Excellence Award

Director General/CEO | The University of Kenya Institute of Primate Research | Kenya

Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems.

                            Citation Metrics ( Scopus )

300

250

200

150

100

50

0

 

Citations
169
documents
16
h-index
8

Citations

Documents

h-index

 

George Vaos | Medicine | Stellar Contributions to Science Award

Published on by Environmental Scientists

Prof. Dr. George Vaos | Medicine | Stellar Contributions to Science Award

Prof. Dr. George Vaos | Medicine | National and Kapodistrian University of Athens | Greece

Prof. Dr. George Vaos is an internationally recognized male academic and clinician whose scholarly and professional contributions have significantly advanced pediatric surgery and its intersections with public health, clinical epidemiology, and evidence-based medical science. His educational background includes comprehensive medical training followed by advanced doctoral-level education at a prestigious European university, where he developed a strong foundation in surgical sciences, clinical research methodology, and translational medicine, later complemented by continuous academic development within leading medical institutions.

Citation Metrics (Google Scholar)

2500

2000

1500

1000

500

0

.

–

Citations
1817
i10index
43

h-index
24

                  🟦 Citations      🟥 i10index          🟩 h-index

View Google Scholar Profile

Featured Publications:

Multicenter Assessment of Ultrasound of the Spermatic Cord in Children with Acute Scrotum

– The Journal of Urology, 2007 · 254 Citations
Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review

– Digestive Diseases and Sciences, 2013 · 113 Citations
The Role of Calprotectin in Pediatric Disease

– BioMed Research International, 2013 · 108 Citations
Optimal Timing for Repair of an Inguinal Hernia in Premature Infants

– Pediatric Surgery International, 2010 · 88 Citations
Immediate Surgery or Conservative Treatment for Complicated Acute Appendicitis in Children? A Meta-Analysis

– Journal of Pediatric Surgery, 2019 · 81 Citations

 

Ioana Munteanu | Health Sciences | Research Excellence Award

Published on by Environmental Scientists

Dr. Ioana Munteanu | Health Sciences | Research Excellence Award

Dr. Ioana Munteanu | Health Sciences | Senior Physician at National Institute of Pneumology Marius Nasta | Romania

Dr. Ioana Munteanu is a distinguished researcher specializing in environmental health and infectious diseases, with a particular focus on tuberculosis. She completed her Ph.D. at a leading university, where she developed innovative strategies for improving treatment outcomes in vulnerable populations, combining clinical research with public health interventions. Dr. Ioana Munteanu has extensive professional experience leading and collaborating on international research projects across Europe, including studies in Romania and Ukraine that investigate psychosocial and biomedical approaches to tuberculosis management.

Citation Metrics (Scopus)

150

120

90

60

30

0

Citations
109

Documents
42

h-index
6

🟦 Citations 🟥 Documents 🟩 h-index

View Scopus

Featured Publications:


Environmental Contamination and Distribution of Tuberculosis in Romania

– The Handbook of Environmental Chemistry, 2025 ·

Rosamaria Terracciano | Health Sciences | Research Excellence Distinction Award

Published on by Environmental Scientists

Dr. Rosamaria Terracciano | Health Sciences | Research Excellence Distinction Award

Dr. Rosamaria Terracciano | Health Sciences | Università degli Studi di Napoli Federico II | Italy

Dr. Rosa Terracciano is an accomplished biomedical researcher specializing in clinical biochemistry, mass spectrometry-based proteomics/metabolomics, and translational research with significant contributions to male reproductive health and biomarker discovery; she holds advanced academic qualifications in biomedical sciences and has undertaken rigorous training in analytical instrumentation and molecular diagnostics, including high-performance liquid chromatography and tandem mass spectrometry, which form the basis of her expertise in untargeted omics approaches for disease characterization. Dr. Terracciano’s academic foundation was established through comprehensive undergraduate and postgraduate education in the life sciences followed by doctoral and postdoctoral research focused on integrative omics applications in clinical settings, enabling her to bridge cutting-edge laboratory techniques with practical biomedical questions. Over her professional career, she has held research and academic positions at internationally recognized institutions, including the Department of Experimental and Clinical Medicine at Magna Græcia University in Catanzaro, Italy, where she has collaborated extensively with multidisciplinary teams to advance translational research in infertility diagnostics and other metabolic disorders. Dr. Terracciano’s professional experience encompasses leading collaborative projects, supervising junior researchers, and contributing to both experimental design and high-throughput data analysis workflows. Her research interests focus on leveraging untargeted mass spectrometry, metabolomics, lipidomics, and proteomics to identify novel molecular signatures that can improve diagnostic accuracy and deepen understanding of complex pathophysiological mechanisms, particularly in the context of male infertility and seminal plasma biomarker discovery. She has developed strong research skills in omics data acquisition, advanced chromatographic separation, bioinformatics interpretation of large-scale datasets, and clinical sample analysis, all of which support her translational research ethos. Dr. Terracciano’s work has been recognized through multiple peer-reviewed publications and scholarly attention, with several studies cited by other researchers in the field, reflecting her impact on advancing both methodological approaches and clinical insights. Her contributions include original research and comprehensive reviews that integrate methodological innovation with practical clinical relevance. In conclusion, Dr. Rosa Terracciano continues to be a prominent figure in biomedical research, dedicated to the discovery and validation of biomarkers through state-of-the-art mass spectrometry-based platforms, with an emphasis on translating laboratory findings into clinical and diagnostic advancements that benefit patient care and reproductive health research.

Academic Profile: Scopus

Featured Publications:

Tosco, A., Cerchione, R., Gelzo, M., Cimbalo, C., Castaldo, A., Terracciano, R., Raia, V., & Sepe, A. (2025). Hemoglobin levels in children treated for cystic fibrosis with CFTR modulators: A single center retrospective study. Journal of Clinical Medicine, 14(14), 4856. https://doi.org/10.3390/jcm14144856

 

 

 

Giorgio Maria Baldini | Health Science | Best Researcher Award

Published on by Environmental Scientists

Dr. Giorgio Maria Baldini | Health Science | Best Researcher Award

Resident Obstetrics and Gynaecology Unit, Department of Interdisciplinary Medicine (DIM), University of Bari, 70124 Bari, Italy

Dr. Giorgio Maria Baldini is an emerging Italian medical professional and researcher in Obstetrics and Gynecology. With over 40 peer-reviewed publications and active roles in assisted reproduction and AI applications in gynecology, he combines clinical excellence with innovation. Currently a specialist-in-training at AO Policlinico Bari, he has made impactful contributions to reproductive medicine through both clinical practice and scientific inquiry. 🌟

Professional Profile

Scopus

Orcid

🎓 Education

Dr. Baldini earned his Master’s Degree in Medicine and Surgery with honors (cum laude) from the University of Bari Aldo Moro in 2022. He holds a Level I Master’s in Endocrinology and Reproductive Medicine from the University of Foggia and is pursuing specialization in Obstetrics and Gynecology, first at AOU Sassari (2022–2023) and currently at Policlinico of Bari. 📘🩺

💼 Experience

He served as a research fellow and later as a medical doctor at MOMÒ FertiLIFE IVF Center, Bisceglie (2019–2022), contributing to clinical innovation in fertility. Since December 2023, he has been a specialist trainee at the AO Policlinico of Bari, enhancing his academic and clinical exposure. Previously, he trained at AOU Sassari (2022–2023) in the Obstetrics and Gynecology Unit. 🏥🔬

🔬 Research Interests

His research focuses on artificial intelligence in gynecology, fertility preservation, environmental impacts on reproductive health, and ultrasound diagnostics. He explores the interface of tech-driven healthcare and personalized reproductive medicine. His work often blends medical imaging, AI tools, and hormone-sensitive conditions to optimize care and outcomes. 🤖🧫👩‍⚕️

🏆 Awards

While still early in his career, Giorgio Baldini has been recognized with high-impact publications, over 40 indexed articles, and two book chapters. With an H-index of 6, he has participated in over 10 scientific congresses, including four as a speaker. His scholarly presence and rapid output are indicative of a future thought leader in women’s health and reproductive technologies. 🏅📚

📚 Top Noted Publications

“Does Electromagnetic Pollution in the ART Laboratory Affect Sperm Quality?”
🗞 Toxics (2025)
🔗 Read
📌 Cited by multiple discussions on ART lab conditions in fertility science.

“Artificial Intelligence and Uterine Fibroids”
🗞 Journal of Clinical Medicine (2025)
🔗 Read
📌 Cited in emerging reviews on AI in gynecological diagnostics.

“Artificial Intelligence in Placental Pathology”
🗞 Journal of Imaging (2025)
🔗 Read
📌 Referenced for innovative imaging applications in placental assessment.

“Uterine Rupture Following Prostaglandins in Second Trimester”
🗞 International Journal of Gynecology & Obstetrics (2025)
🔗 Read
📌 Influential in abortion safety and pharmacological risk assessments.

“Polycyclic Aromatic Hydrocarbons (PAHs): Fertility Implications”
🗞 Toxics (2025)
🔗 Read
📌 Cited in occupational exposure studies linked to reproductive risk.

“Borderline Ovarian Tumors: A Fertility-Sparing Algorithm”
🗞 International Journal of Gynecological Cancer (2025)
🔗 Read
📌 Cited in guidelines on fertility-preserving oncology.

“Doctor Chat-GPT: AI Language Models for BRCA Patient Education”
🗞 International Journal of Gynecological Cancer (2025)
🔗 Read
📌 Groundbreaking article intersecting AI and patient education.

“Precision Probiotic Intervention in Infertile Women”
🗞 Microorganisms (2025)
🔗 Read
📌 Cited in microbiome and fertility restoration research.

Conclusion

Given his rapid scientific productivity, multidisciplinary innovation, and growing influence in reproductive medicine, Dr. Giorgio Maria Baldini is a highly suitable candidate for the Best Researcher Award. His blend of clinical excellence and research creativity sets a solid foundation for continued contributions to women’s health globally. With his trajectory, he stands out as a future leader in medical science. 🏅🌐🔬

Sang-Hoon Lee | Medicine | Best Researcher Award

Published on by Environmental Scientists

Dr. Sang-Hoon Lee | Medicine | Best Researcher Award

Physician, GreenCross I-MED Gangnam Medical Center, South Korea

Dr. Sang-Hoon Lee is a distinguished medical professional specializing in Family Medicine and Functional Medicine 🩺. With over a decade of experience across diverse clinical settings in Korea, he combines evidence-based medical care with a deep interest in personalized and integrative treatments. He has held various leadership roles, contributed actively to global scientific discussions, and participated in multiple clinical trials. A dedicated educator and researcher, Dr. Lee’s work spans geriatrics, vitamin D metabolism, and chronic fatigue-related disorders. His clinical insight and academic excellence have earned him recognition in both Korean and international medical communities 🌍.

Profile

Google Scholar

🎓 Education

Dr. Lee earned his M.D. from Ajou University School of Medicine, Korea (2001–2008), where he was a recipient of multiple academic excellence scholarships and awards 🏅. He pursued his M.Med. in Family Medicine from Ajou University Graduate School (2009–2012), presenting a notable thesis on calcium pools in the body. His global exposure includes a visiting clerkship in pediatrics and family medicine at Stony Brook University Medical Center, NY, USA, and English language courses in the UK 🇰🇷🇺🇸🇬🇧.

🩺 Experience

Currently serving at Greencross I-MED Gangnam Center (since 2021), Dr. Lee has held key positions such as Head of Family Medicine at Gangnam Weedahm Oriental Hospital and Magnus Rehabilitation Hospital 🏥. His journey includes leadership, clinical fellowships, and advisory roles across institutions like Abbvie Korea and Ajou University Medical Center. He has been actively involved in national and international medical symposiums and education programs, especially in gastroenterology and geriatrics 👨‍⚕️📚.

🔬 Research Interest

Dr. Lee’s research interests span bone mineral density, calcium metabolism, vitamin D deficiency, gastrointestinal disorders, geriatrics, and functional medicine 🧪🦴. His multidisciplinary focus integrates clinical experience with research on nutrition, endocrinology, and chronic fatigue. He has contributed to the scientific understanding of the relationship between hair calcium, BMD, and coronary calcium scores, as well as the effectiveness of synbiotics in IBS patients 🌿🔍.

🏆 Awards

Throughout his academic and clinical career, Dr. Lee has received numerous accolades 🎖️. He won prizes in English essay competitions, oral presentations at the Korean Academy of Family Medicine (2011), and was invited to present at the UEG Week (Barcelona 2015) and WONCA Seoul (2019). He also earned recognition from Ajou University’s President for leadership and academic excellence 🥇📢.

📚 Publications

Effect of sunlight exposure on serum 25-hydroxyvitamin D concentration in women with vitamin D deficiency
Korean J Fam Med, 2012; 33(6): 381-9 ☀️
Cited for ambulatory light measurement techniques in Vitamin D studies.

Hair calcium concentration is associated with calcium intake and bone mineral density
Int J Vitam Nutr Res, 2013; 83(3): 154-61 💇‍♂️
Referenced in nutritional epidemiology and mineral research studies.

Coronary calcification is reversely related with bone and hair calcium
J Bone Metab, 2016; 23: 191–197 ❤️🦴
Used in cross-disciplinary calcium pool investigations.

Symptomatic Hyponatremia After Using Low-Dose Combination Diuretics
Korean J Clin Geri, 2016; 17(2): 79–84 💊
Cited in clinical geriatric medicine and case-based reviews.

A randomized clinical trial of synbiotics in irritable bowel syndrome
Korean J Fam Med, 2019; 40(1): 2–8 🍽️
Noted for dose-effect relationships in gut microbiota therapy.

Low bone mineral density is associated with high frequency hearing impairment in women over 50
Korean J Fam Med, 2024; ePub 👂🦴
Cited in emerging research on bone and auditory health.

Human Placenta Hydrolysate Protects Against Acetaminophen-Induced Liver Injury
Biomedicines, 2025; 13:1219 🧬🩸
Used in regenerative medicine and hepatology discussions.

🏁 Conclusion

Sang-Hoon Lee’s impressive clinical experience, research publications, and professional memberships make him a strong candidate for the Best Researcher Award. His contributions to the field of family medicine and related areas demonstrate his commitment to advancing medical knowledge and practice. With some focus on interdisciplinary research and global collaborations, Lee could further strengthen his research profile and impact ¹.